Achieving clinical success with BET inhibitors as anti-cancer agents

The transcriptional upregulation of oncogenes is a driving force behind the progression of many tumours. However, until a decade ago, the concept of ‘switching off’ these oncogenic pathways represented a formidable challenge. Research has revealed that members of the bromo- and extra-terminal domain...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of cancer Ročník 124; číslo 9; s. 1478 - 1490
Hlavní autoři:	Shorstova, Tatiana, Foulkes, William D., Witcher, Michael
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 27.04.2021 Nature Publishing Group
Témata:	631/67/1059/602 692/53/2423 Antineoplastic Agents - therapeutic use Antitumor agents Biomarkers Biomedical and Life Sciences Biomedicine Cancer Research Chromatin Drug Resistance Epidemiology Humans Molecular Medicine Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - pathology Oncology Prognosis Proteins - antagonists & inhibitors Review Review Article Transcription Transcription Factors - antagonists & inhibitors Tumors
ISSN:	0007-0920, 1532-1827, 1532-1827
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!